Close
  Indian J Med Microbiol
 

Figure 1: Receiver operating characteristic curve curve for different parameters to predict malignant gastric ulcer versus benign gastric ulcer: (a) without combination, (b) combined with carcinoembryonic antigen (CEA), (c) combined with carbohydrate antigen 19-9 (CA 19-9), (d) combined with all parameters. CA 19-9, carbohydrate antigen 19-9; CEA, carcinoembryonic antigen; MPV, mean platelet volume; PDW, platelet distribution width.

Figure 1: Receiver operating characteristic curve curve for different parameters to predict malignant gastric ulcer versus benign gastric ulcer: (a) without combination, (b) combined with carcinoembryonic antigen (CEA), (c) combined with carbohydrate antigen 19-9 (CA 19-9), (d) combined with all parameters. CA 19-9, carbohydrate antigen 19-9; CEA, carcinoembryonic antigen; MPV, mean platelet volume; PDW, platelet distribution width.